Many factors must be considered and discussed with women when initiating a contraceptive
method and the risk of venous thromboembolism (VTE) is one of them. In this review, we …

The need to seek improved combined oral contraceptive (COC) efficacy, with fewer health
risks and better acceptability, has been ongoing since the introduction of COCs more than …

BACKGROUND In recent years, several new oral contraceptives have become available. In
some ways, they represent an evolution in terms of individualization and compliance on the …

Dienogest (DNG) is a 19-nortestosterone derivative (a C-19 progestogen) with a
cyanomethyl instead of an ethinyl group at the C-17 position, which may make the …

Introduction: Is the replacement of ethinyl-estradiol (EE) with estradiol (E2) in combined
hormonal contraceptives (CHCs) associated with fewer metabolic effects, leading to a further …

Nomegestrol acetate (NOMAC) is a 19-norprogesterone derivative with high biological
activity at the progesterone receptor, a weak anti-androgenic effect, but with no binding to …

Abstract Objective Combined oral contraceptives (COCs) containing ethinyl-estradiol are
known to increase blood pressure (BP). We evaluated whether COCs containing estradiol …

The second more frequently used contraception method in our country is hormonal
contraception. Innovations in composition include the introduction of estradiol valerate as …

Hormonal contraceptives, in particular combined oral contraceptives (COCs), were designed
to avoid unintended pregnancy, with the fewest possible side effects and health risks. The …

Aim: To observe the influence on metabolism and body composition of two oral
contraceptives containing non-androgenic progestins in association with estradiol or ethinyl …